The Memorial Sloan Kettering Prognostic Score (MPS) is an alternative to the Glasgow Prognostic Score. It correlates with survival in metastatic pancreatic adenocarcinoma and other tumors.
Parameters:
(1) serum albumin in g/dL
(2) neutrophil to lymphocyte ratio (NLR)
NLR =
= (neutrophil count) / (lymphocyte count)
Serum Albumin
NLR
MPS
>= 4 g/dL
<= 4
0
< 4 g/dL
<= 4
1
>= 4 g/dL
> 4
1
< 4
> 4
2
The higher the MPS the worse the prognosis.
To read more or access our algorithms and calculators, please log in or register.
